Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 2, 2018 - Issue 1
1,003
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

What is the relative contribution of biological and psychosocial factors to the generation of hypoxia headache?

, & ORCID Icon
Pages 160-168 | Received 26 Mar 2018, Accepted 15 May 2018, Published online: 22 Jun 2018

References

  • Engel G. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–136. doi:10.1126/science.847460.
  • Moseley GL , Butler DS. Fifteen years of explaining pain—the past, present and future. J Pain. 2015;16:807–813. doi:10.1016/j.jpain.2015.05.005.
  • Astin JA , Shapiro SL , Eisenberg DM , Forys KL. Mind–body medicine: state of the science, implications for practice. J Am Board Fam Pract. 2003;16:131–147. doi:10.3122/jabfm.16.2.131.
  • Campbell CM , Edwards RR . Mind–body interactions in pain: the neurophysiology of anxious and catastrophic pain-related thoughts. Transl Res. 2009;153:97–101. doi:10.1016/j.trsl.2008.12.002.
  • Ray O . How the mind hurts and heals the body. Am Psychologist. 2004;76:288–294.
  • Van Oudenhove L , Cuypers S . The relevance of the philosophical “mind–body problem” for the status of psychosomatic medicine: a conceptual analysis of the biopsychosocial model. Medicine, Health Care and Philosophy. 2014;17:201–213. doi:10.1007/s11019-013-9521-1.
  • Benedetti F . How the doctor’s words affect the patient’s brain. Eval Health Prof. 2002;25:369–386. doi:10.1177/0163278702238051.
  • Benedetti F . Placebo and the new physiology of the doctor–patient relationship. Physiol Rev. 2013;93:1207–1246. doi:10.1152/physrev.00043.2012.
  • Peerdeman KJ , Van Laarhoven AIM , Keij SM , Vase L , Rovers MM , Peters ML , Evers AW . Relieving patients’ pain with expectation interventions : a meta-analysis. Pain. 2016;157:1179–1191. doi:10.1097/j.pain.0000000000000540.
  • Tracey I . Getting the pain you expect : mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16:1277–1283. doi:10.1038/nm.2229.
  • Benedetti F , Amanzio M , Casadio C , Oliaro A , Maggi G . Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain. 1997;71:135–140. doi:10.1016/S0304-3959(97)03346-0.
  • Benedetti F , Amanzio M , Vighetti S , Asteggiano G . The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26:12014–12022. doi:10.1523/JNEUROSCI.2947-06.2006.
  • Colloca L , Finniss D . Nocebo effects, patient–clinician communication, and therapeutic outcomes. JAMA. 2012;307:567–568. doi:10.1001/jama.2012.115.
  • Mogil JS . Social modulation of and by pain in humans and rodents. Pain. 2015;156:S35–S41. doi:10.1097/01.j.pain.0000460341.62094.77.
  • Benedetti F , Durando J , Vighetti S . Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase–prostaglandins pathway. Pain. 2014;155:921–928. doi:10.1016/j.pain.2014.01.016.
  • Colloca L . Nocebo effects can make you feel pain. Science. 2017;358:44. doi:10.1126/science.aap8488.
  • Tinnermann A , Geuter S , Sprenger C , Finsterbusch J , Büchel C . Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia. Science. 2017;358:105–108. doi:10.1126/science.aan1221.
  • Benedetti F . Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014;84:623–637. doi:10.1016/j.neuron.2014.10.023.
  • Gordon A . The five pillars of pain management. Pain Manag. 2012;2:335–344. doi:10.2217/pmt.12.31.
  • Keefe FJ , Porter L , Somers T , Shelby R , Wren AV . Psychosocial interventions for managing pain in older adults : outcomes and clinical implications. Br J Anaest. 2013;111:89–94. doi:10.1093/bja/aet129.
  • Benedetti F , Dogue S . Different placebos, different mechanisms, different outcomes : lessons for clinical trials. PLoS ONE. 2015;10:e0140967. doi:10.1371/journal.pone.0140967.
  • Benedetti F , Durando J , Giudetti L , Pampallona A , Vighetti S . High-altitude headache : the effects of real vs sham oxygen administration. Pain. 2015;2:2326–2336. doi:10.1097/j.pain.0000000000000288.
  • Andrasik F , Flor H , Turk D . An expanded view of psychological aspects in head pain : the biopsychosocial model. Neurol Sci. 2005;26:S87–S91. doi:10.1007/s10072-005-0416-7.
  • Kröner-Herwig B , Morris L , Heinrich M . Biopsychosocial correlates of headache : what predicts pediatric headache occurrence? Headache. 2007;48:529–544. doi:10.1111/j.1526-4610.2007.00945.x.
  • Leonardi M , Raggi A , Grazzi L , Amico DD . Disability, ICF biopsychosocial model and burden of migraine. J Headache Pain. 2015;16:6–7. doi:10.1186/1129-2377-16-S1-A2.
  • Martin PR , Forsyth MR , Reece J . Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther. 2007;38:350–363. doi:10.1016/j.beth.2006.10.004.
  • Nicholson RA , Houle TT , Rhudy JL , Norton PJ . Psychological risk factors in headache. Headache. 2007;47:413–426.
  • Sutton JP , Coates G , Houston CS , Hackett PH , Oelz O . Hypoxia and mountain medicine. In: Sutton JR , Coates G , Houston CS , editors. Hypoxia and mountain medicine. Burlington, VT: Queen City Printers; 1992. p. 327–330.
  • Imray C , Wright A , Subudhi A , Roach R . Acute mountain sickness : pathophysiology, prevention, and treatment. Prog Cardiovasc Dis. 2010;52:467–484. doi:10.1016/j.pcad.2010.02.003.
  • Wilson MH , Newman S , Imray CH . The cerebral eff ects of ascent to high altitudes. Lancet Neurol. 2009;8:157–191. doi:10.1016/S1474-4422(09)70014-6.
  • Amano T , Meyer JS . Prostaglandin inhibition and cerebrovascular control in patients with headache. Headache. 1982;22:52–59. doi:10.1111/hed.1982.22.issue-2.
  • Richalet JI , Hornych A , Rathat C , Aumont J , Larmignat P . Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Resp Physiol. 1991;85:205–215. doi:10.1016/0034-5687(91)90062-N.
  • Tassorelli C , Greco R , Armentero M , Blandini F , Sandrini G , Nappi G . A role for brain cyclooxygenase-2 and prostaglandine-e2 in migraine: effects of nitroglycerin. Int Rev Neurobiol. 2007;82:373–382.
  • Tuca JO , Planas JM , Parellada RP . Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache. 1989;29:498–501. doi:10.1111/hed.1989.29.issue-8.
  • Wienecke T , Olesen J , Oturai PS , Ashina M . Prostaglandin E2 (PGE2) induces headache in healthy subjects. Cephalagia. 2009;29:509–519. doi:10.1111/j.1468-2982.2008.01748.x.
  • Busse R , Förstermann U , Matsuda H , Pohl U . The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia. Pflügers Arch Eur J Physiol. 1984;401:77–83. doi:10.1007/BF00581536.
  • Davis RJ , Murdoch CE , Ali M , Purbrick S , Ravid R , Gordon S , Coleman RA . EP 4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol. 2004;141:580–585. doi:10.1038/sj.bjp.0705645.
  • Fredricks KT , Liu Y , Rusch NJ , Lombard JH . Role of endothelium and arterial K+ channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol. 1994;267:H580–H586.
  • Messina EJ , Sun D , Koller A , Wolin MS , Kaley G . Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circul Res. 1992;71:790–797. doi:10.1161/01.RES.71.4.790.
  • Ray CJ , Abbas MR , Coney AM , Marshall JM . Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation : in vivo and in vitro studies. J Physiol. 2002;544:195–209. doi:10.1113/jphysiol.2002.023440.
  • Kawabata A . Lipid mediators and pain signaling: prostaglandin E2 and pain—an update. Biol Pharm Bull. 2011;34:1170–1173. doi:10.1248/bpb.34.1170.